meta_pixel
Tapesearch Logo
Log in
Emergency Medicine Cases

Episode 15 Part 2: Acute Coronary Syndromes Management

Emergency Medicine Cases

Dr. Anton Helman

Science, Courses, Medicine, Health & Fitness, Education

4.7602 Ratings

🗓️ 21 June 2011

⏱️ 89 minutes

🧾️ Download transcript

Summary

In Part 2 of this Episode on Acute Coronary Syndromes Risk Stratification & Management, the evidence for various medications for ACS, from supplemental oxygen to thrombolytics are debated, and decision making around reperfusion therapy for STEMI as well as NSTEMI are discussed. Finally, there is a discussion on risk stratification of low risk chest pain patients and all it's attendant challenges as well as disposition and follow-up decisions. Dr. Eric Letovsky, the Head of the CCFP(EM) Program at the University of Toronto, Dr. Mark Mensour & Dr. Neil Fam, an interventional cardiologist answer questions like: What is the danger of high flow oxygen in the setting of ACS? When, if ever, should we be using IV B-blockers in AMI patients? How can you predict, in the ED, who might go on to have an urgent CABG, in which case Clopidogrel is contra-indicated? Which anticoagulant is best for unstable angina, NSTEMI and STEMI - unfractionated heparin (UFH), low molecular weight heparin (LMWH), or fonduparinux? Is there currenly any role for Glycoprotein 2b3a Inhibitors in ACS in the ED? When is thrombolysis better than PCI for STEMI? When should we consider facilitated angioplasty and rescue angioplasty? Which low risk chest pain patients require an early stress test? CT coronary angiography? Stress Echo? Admission to a Coronary Decision Unit (CDU)? and many more.......

Transcript

Click on a timestamp to play from that location

0:00.0

Let's move on to cardiac markers. Dr. Latovsky, before we talk about troponins, I'd like to discuss a bit about

0:07.6

KMB. It seems to me that KMB has become sort of an ancient relic, a thing of the past.

0:15.2

In what situations would a KMB be useful in 2011?

0:20.3

Well, we still run CKs along with our triponins. We often get the CK result actually earlier before our triponants, so it often tells us right away that, you know, the patient's chest being really is a schemic. We can start anti-plately and antithrombotic earlier because our CK comes back about 15 minutes earlier than our antipotin for some reason.

0:56.4

The other time that a CK may be of value is because of the long half-life of a triponin and may not clear for 7 to 10 days. If someone gets discharged from the hospital within three days of acute infarction or four days in acute infarction, they come back with pain, then the CK, which will have cleared earlier if it's a rise you can sometimes diagnose re-infarction or re-aschemia with an elevation of the ck so that'd probably be the you know the two reasons why

1:01.5

cKs are still a valuable biochemical marker in my opinion dr otofsky do you always do

1:07.8

two sets of troponins on your patients you suspect of ACS,

1:11.9

who haven't immediately left your department because of a stemmy?

1:15.7

For example, let's say our elderly patient with this presumed new left bundle branch block

1:21.7

is not taken to the cath lab, is not given thrombolysis,

1:24.9

and her pain started 15 hours ago instead of four hours ago.

1:29.6

Presumely, since the peak sensitivity of troponin for MI is about 10 to 12 hours, you'd only need to

1:36.8

do one set of troponins. Do you ever only do one set of troponins? What's your take on that?

1:43.4

I do, but it's not common. Remember, the majority of patients who present with a

1:48.2

Kipmacharninfar infarction present within about three hours of the illness of the chest pain.

1:52.4

So the overwhelming number of patients who present with chest pain have a recent onset of chest pain.

1:58.4

And that patient population would be wrong to assume that a single

2:04.1

tripon excludes my carnal fraction. So that's, so the majority of our patients, if they present

2:09.9

with, you know, a chest pain for an hour, two, or three, and their pain has disappeared,

2:16.0

those are the kind of patients you really need to hold for a second state of cardiac markers eight, nine, ten hours after the onset of their chest pain. Do I ever rely on a single set of cardiac markers in the answer? I do. It's not common, but I do. If the pain was yesterday and they come in today, because they want it to be checked out, and the opponent is completely negative, that will will reassure me and I won't do a set of cardiac markers on those patients

2:38.2

if the pain was yesterday the day before.

2:40.1

I don't think there's any value in holding them two hours or four hours later for a second

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Dr. Anton Helman, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Dr. Anton Helman and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.